Thompson Siegel & Walmsley LLC Grifols Sa Transaction History
Thompson Siegel & Walmsley LLC
- $6.24 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding GRFS
# of Institutions
147Shares Held
151MCall Options Held
2.38MPut Options Held
662K-
Capital World Investors Los Angeles, CA20.9MShares$171 Million0.02% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA18.6MShares$152 Million1.52% of portfolio
-
Permian Investment Partners, LP New York, NY14.1MShares$116 Million11.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny13.9MShares$114 Million0.04% of portfolio
-
Black Creek Investment Management Inc. Toronto, A612.3MShares$101 Million2.9% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $5.57B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...